Postdoctoral Associate - Pharmacoepidemiology/Health Informatics

The final salary offer may be determined by several factors, including, but not limited to, the candidate’s qualifications, experience, and expertise, and availability of department or grant funds to support the position. We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university’s broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include:

Postdoctoral Research Associate- The Postdoctoral Research Associate will join a multidisciplinary research team focused on cognitive aging and health and Alzheimer’s disease and related dementias. Reporting to the Principal Investigator on grant-funded projects, the individual will play a key role in supporting laboratory operations and advancing ongoing research initiatives.

Primary responsibilities include:

The candidate must demonstrate a strong record of accomplishment in a relevant area of research, as evidenced by peer-reviewed publications. Expertise in pharmacoepidemiology methods and specific dementia/drug safety and interactions is highly desirable. In addition to experimental work, the Postdoctoral Research Associate will contribute to mentoring and training staff and students, assist in experimental design and planning, and help introduce and develop new technical approaches within the group. The individual will collaborate with other research teams involved in NIH-funded projects, and participate in group meetings

About the Herbert and Jacqueline Krieger Klein Alzheimer’s Center:
Founded in 2023, the Herbert and Jacqueline Krieger Klein Alzheimer’s Center: is fully dedicated to accelerating the discovery of new treatments for Alzheimer’s and related dementias. This center marks a significant milestone—it is the very first of its kind in our state’s history. In New Jersey, around 200,000 individuals suffer from Alzheimer’s disease, and a larger number of older adults are at high risk for developing the disease. Our mission is clear: to lead the way in finding solutions to prevent and treat this devastating disease. With a focus on translating groundbreaking research into real-world impact, our team is committed to improving the lives of individuals, families, and communities affected by Alzheimer’s. Through collaboration and innovation, we aim to deliver meaningful outcomes for those at risk and currently battling the disease.

Rutgers, The State University of New Jersey, is a leading national research university. Its partners form one of the nation’s largest academic health care systems, and the largest in New Jersey. The Herbert and Jacqueline Krieger Klein Alzheimer’s Center is a Brain Health Institute (BHI) center. By reporting to Rutgers New Brunswick and Rutgers Health, and being administered by Rutgers Health, BHI serves as a unifying entity that fosters collaboration and integration, driving forward advancements in neuroscience research and education. The Herbert and Jacqueline Krieger Klein Alzheimer’s Center is located at in the center of New Brunswick, about an hour away from New York City, at the Institute for Health, Health Care Policy, and Aging Research building.